Clinical

Dataset Information

Therapy in combination with capecitabine, cetuximab and oxaliplatin


ABSTRACT: Primary objectives: investigation of a possible modulation of co-administered CETUX on the metabolic activation of CCB Primary endpoints: A metabolic activation of CCB modulated by co-administered CETUX is to be expected

DISEASE(S): Metastatic Colorectal Cancer,This Study Is Designed As A Multicentre, Parallel Group Phase Ii Trial With 24 First-line Patients With Metastatic K-ras Wild Type Crc. The Objective Of This Pharmacokinetic Study Is To Exclude A...,This Study Is Designed As A Multicentre, Parallel Group Phase Ii Trial With 24 First-line Patients With Metastatic K-ras Wild Type Crc. the Objective Of This Pharmacokinetic Study Is To Exclude A Probable Influence Of Cetux On The Plasma Disposition And Metabolic Activation Of Ccb And When This Regimen Is Given Combined With Oxpt.,Colorectal Cancer Metastatic

PROVIDER: 2529757 | ecrin-mdr-crc |

REPOSITORIES: ECRIN MDR